AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral SclerosisAstraZeneca's 39 billion USD complete a...
Alzheimer's Association International Conference (AAIC) 2021 Opens With Thrilling Details of Pharmas and Powerful Therapeutic Discoveries The most awaited Alzheimer’s Association Internat...
Uncomplicated Urinary Tract Infections are one of the most commonly diagnosed infections in the US, with the maximum prevalence in women who are sexually active. A wide range of pathogens can be a...
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High-Frequency Nerve Block SystemOn June 29, 2021, the US Food and Drug Administration (FDA) granted Neuros Me...
Hepion Pharma's NASH drug is set for Phase 2b after clearing the safety barHepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic drugs fo...
Bayer Scores FDA-Approval for its CKD Drug FinerenoneFollowing a priority review, the USFDA finally gave its thumbs-up to Bayer AG’s Kerendia (finerenone) for chronic kidney disease (CKD) asso...
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
